| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,712 |
27,767 |
$1.81M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,567 |
7,721 |
$633K |
| S8301 |
Infection control supplies, not otherwise specified |
21,680 |
15,684 |
$507K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
19,045 |
16,014 |
$506K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,910 |
7,891 |
$403K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,524 |
2,497 |
$193K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,427 |
2,329 |
$180K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,122 |
2,110 |
$171K |
| 99215 |
Prolong outpt/office vis |
2,241 |
1,909 |
$161K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,855 |
3,416 |
$122K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,084 |
1,062 |
$91K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,846 |
3,132 |
$30K |
| 99381 |
|
347 |
321 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,469 |
1,305 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
103 |
95 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
671 |
460 |
$7K |
| 87634 |
|
66 |
63 |
$4K |
| 87807 |
|
302 |
266 |
$3K |
| 81002 |
|
663 |
565 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
118 |
111 |
$1K |
| 96160 |
|
344 |
344 |
$572.76 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
555 |
376 |
$357.70 |
| 99072 |
|
18 |
16 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,477 |
1,195 |
$0.00 |
| 99401 |
|
157 |
135 |
$0.00 |